Exact Mass: 391.14080160000003
Exact Mass Matches: 391.14080160000003
Found 500 metabolites which its exact mass value is equals to given mass value 391.14080160000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tetrahydropalmatine hydrochloride
C21H25NO4.HCl (391.1550266000001)
Tetrahydropalmatine hydrochloride (Gindarine hydrochloride) is an isoquinoline alkaloid found in several different plant species, mainly in the Corydalis genus (Yan Hu Suo). It is a potent muscle relaxant. Tetrahydropalmatine (THP) is an isoquinoline alkaloid found in several different plant species, mainly in the genus Corydalis (Yan Hu Suo),[1][2] but also in other plants such as Stephania rotunda.[3] These plants have traditional uses in Chinese herbal medicine. The pharmaceutical industry has synthetically produced the more potent enantiomer Levo-tetrahydropalmatine (Levo-THP), which has been marketed worldwide under different brand names as an alternative to anxiolytic and sedative drugs of the benzodiazepine group and analgesics such as opiates. It is also sold as a dietary supplement. In 1940, a Vietnamese scientist Sang Dinh Bui extracted an alkaloid from the root of Stephania rotunda with the yield of 1.2–1.5\\\\% and he named this compound rotundine. From 1950 to 1952, two Indian scientists studied and extracted from Stephania glabra another alkaloid named hyndanrine. In 1965, the structure of rotundine and hyndarin was proved to be the same as tetrahydropalmatine.[4] 6H-Dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, hydrochloride (1:1). CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2506-20-9 (retrieved 2024-07-09) (CAS RN: 6024-85-7). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1]. Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1]. Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1].
Glycoperine
Glycoperine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound and an oxacycle. Glycoperine is a natural product found in Haplophyllum acutifolium and Haplophyllum latifolium with data available.
Linopirdine
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D020011 - Protective Agents Same as: D04741
Hexylglutathione
C16H29N3O6S (391.17769740000006)
D004791 - Enzyme Inhibitors
Flavoxate
A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist. [PubChem] G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D000089162 - Genitourinary Agents > D064804 - Urological Agents
Orysastrobin
D010575 - Pesticides > D005659 - Fungicides, Industrial > D000073739 - Strobilurins D016573 - Agrochemicals
8-Methylaminoriboflavin
C17H21N5O6 (391.14917660000003)
N-desmethyltoremifene
C25H26ClNO (391.17028160000007)
N-desmethyltoremifene is a metabolite of toremifene. Toremifene citrate is an oral selective estrogen receptor modulator (SERM) which helps oppose the actions of estrogen in the body. Licensed in the United States under the brand name Fareston, toremifene citrate is FDA-approved for use in advanced breast cancer. It is also being evaluated for prevention of prostate cancer under the brand name Acapodene. (Wikipedia)
Chlorohaloperidol
Icotinib
C22H21N3O4 (391.15319860000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-(1-Carboxy-3-carboxanilidopropyl)alanylproline
Zidebactam
C13H21N5O7S (391.11616360000005)
acetylseneciphylline oxide
Acetylseneciphylline N-oxide is a pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen has been replaced by an acetyl group and the tertiary amino function has been oxidised to the corresponding N-oxide. It has a role as a Jacobaea metabolite. It is an acetate ester, a macrocyclic lactone, an olefinic compound, an organic heterotricyclic compound, a pyrrolizine alkaloid and a tertiary amine oxide. It is functionally related to a seneciphylline. A pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen has been replaced by an acetyl group and the tertiary amino function has been oxidised to the corresponding N-oxide.
[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine-14-aceticacid, 13,14-dihydro-13-methyl-, (+)-
2,3,10-trimethoxy-14-methyl-5-oxo-5,7,8,13-tetrahydro-indolo[2,3:3,4]pyrido[2,1-b]quinazolinium betaine|Euxylophorin-C|Euxylophorine C
C22H21N3O4 (391.15319860000005)
1-(2-hydroxy-3-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|11-Acetonyl-O-desmethyl-Dihydroniditin
C23H21NO5 (391.14196560000005)
O-[alpha-L-Arabinopyranosyl(1?6)-beta-D-glucopyranoside-2-Hydroxy-3-methyl-2-butenenitrile
6-Acetonyl-N-methyl-dihydrodecarine
C23H21NO5 (391.14196560000005)
(2R,3S)-3-hydroxy-2-methylbutanenitrile beta-D-glucopyranoside 6?-O-(2?S,3?R)-2?-ethyl-2?,3?-dihydroxybutyrate|microtropin A
1,4,5-TRI-O-ACETYL-3,6-DI-O-METHYL-2-N-METHYLACETAMIDO-2-DEOXYHEXITOL (1-D)
1-(3-hydroxy-2-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|Acetonyl-11-O-Desmethyl-Dihydroniditin
C23H21NO5 (391.14196560000005)
1-(1-hydroxy-2-methoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-13-yl)-propan-2-one|O-Demethyldihydrochelerythrinyl-11-aceton
C23H21NO5 (391.14196560000005)
(S)-2-((S)-2-((S)-2-Amino-4-carboxybutanamido)-4-carboxybutanamido)succinic acid
1-(4-Methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)-4-methyl-5-phenyl-penta-2,4-dien-1-one
Linopirdine
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker D020011 - Protective Agents Same as: D04741
Glycoperine
Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids
PharmaGSID_47330
C21H15F2N5O (391.12446040000003)
CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8922; ORIGINAL_PRECURSOR_SCAN_NO 8921 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8944; ORIGINAL_PRECURSOR_SCAN_NO 8942 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8967; ORIGINAL_PRECURSOR_SCAN_NO 8965 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8982; ORIGINAL_PRECURSOR_SCAN_NO 8980 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8963; ORIGINAL_PRECURSOR_SCAN_NO 8961 CONFIDENCE standard compound; INTERNAL_ID 444; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8988; ORIGINAL_PRECURSOR_SCAN_NO 8987
Ala Ala Cys Gln
Ala Ala Gln Cys
Ala Cys Ala Gln
Ala Cys Gln Ala
Ala Gly Met Asn
Ala Gly Asn Met
Ala Met Gly Asn
Ala Met Asn Gly
Ala Asn Gly Met
Ala Asn Met Gly
Ala Asn Ser Thr
Ala Asn Thr Ser
Ala Gln Ala Cys
Ala Gln Cys Ala
Ala Gln Ser Ser
Ala Ser Asn Thr
Ala Ser Gln Ser
Ala Ser Ser Gln
Ala Ser Thr Asn
Ala Thr Asn Ser
Ala Thr Ser Asn
Cys Ala Ala Gln
Cys Ala Gln Ala
Cys Gly Gly Arg
C13H25N7O5S (391.16378000000003)
Cys Gly Asn Val
Cys Gly Arg Gly
C13H25N7O5S (391.16378000000003)
Cys Gly Val Asn
Cys Asn Gly Val
Cys Asn Val Gly
Cys Gln Ala Ala
Cys Arg Gly Gly
C13H25N7O5S (391.16378000000003)
Cys Val Gly Asn
Cys Val Asn Gly
Asp Gly Asn Ser
Asp Gly Ser Asn
Asp Asn Gly Ser
Asp Asn Ser Gly
Asp Ser Gly Asn
Asp Ser Asn Gly
Gly Ala Met Asn
Gly Ala Asn Met
Gly Cys Gly Arg
C13H25N7O5S (391.16378000000003)
Gly Cys Asn Val
Gly Cys Arg Gly
C13H25N7O5S (391.16378000000003)
Gly Cys Val Asn
Gly Asp Asn Ser
Gly Asp Ser Asn
Gly Gly Cys Arg
C13H25N7O5S (391.16378000000003)
Gly Gly Met Gln
Gly Gly Gln Met
Gly Gly Arg Cys
C13H25N7O5S (391.16378000000003)
Gly Met Ala Asn
Gly Met Gly Gln
Gly Met Asn Ala
Gly Met Gln Gly
Gly Asn Ala Met
Gly Asn Cys Val
Gly Asn Asp Ser
Gly Asn Met Ala
Gly Asn Ser Asp
Gly Asn Thr Thr
Gly Asn Val Cys
Gly Gln Gly Met
Gly Gln Met Gly
Gly Gln Ser Thr
Gly Gln Thr Ser
Gly Arg Cys Gly
C13H25N7O5S (391.16378000000003)
Gly Arg Gly Cys
C13H25N7O5S (391.16378000000003)
Gly Ser Asp Asn
Gly Ser Asn Asp
Gly Ser Gln Thr
Gly Ser Thr Gln
Gly Thr Asn Thr
Gly Thr Gln Ser
Gly Thr Ser Gln
Gly Thr Thr Asn
Gly Val Cys Asn
Gly Val Asn Cys
Met Ala Gly Asn
Met Ala Asn Gly
Met Gly Ala Asn
Met Gly Gly Gln
Met Gly Asn Ala
Met Gly Gln Gly
Met Asn Ala Gly
Met Asn Gly Ala
Met Gln Gly Gly
Asn Ala Gly Met
Asn Ala Met Gly
Asn Ala Ser Thr
Asn Ala Thr Ser
Asn Cys Gly Val
Asn Cys Val Gly
Asn Asp Gly Ser
Asn Asp Ser Gly
Asn Gly Ala Met
Asn Gly Cys Val
Asn Gly Asp Ser
Asn Gly Met Ala
Asn Gly Ser Asp
Asn Gly Thr Thr
Asn Gly Val Cys
Asn Met Ala Gly
Asn Met Gly Ala
Asn Ser Ala Thr
Asn Ser Asp Gly
Asn Ser Gly Asp
Asn Ser Thr Ala
Asn Thr Ala Ser
Asn Thr Gly Thr
Asn Thr Ser Ala
Asn Thr Thr Gly
Asn Val Cys Gly
Asn Val Gly Cys
Gln Ala Ala Cys
Gln Ala Cys Ala
Gln Ala Ser Ser
Gln Cys Ala Ala
Gln Gly Gly Met
Gln Gly Met Gly
Gln Gly Ser Thr
Gln Gly Thr Ser
Gln Met Gly Gly
Gln Ser Ala Ser
Gln Ser Gly Thr
Gln Ser Ser Ala
Gln Ser Thr Gly
Gln Thr Gly Ser
Gln Thr Ser Gly
Arg Cys Gly Gly
C13H25N7O5S (391.16378000000003)
Arg Gly Cys Gly
C13H25N7O5S (391.16378000000003)
Arg Gly Gly Cys
C13H25N7O5S (391.16378000000003)
Ser Ala Asn Thr
Ser Ala Gln Ser
Ser Ala Ser Gln
Ser Ala Thr Asn
Ser Asp Gly Asn
Ser Asp Asn Gly
Ser Gly Asp Asn
Ser Gly Asn Asp
Ser Gly Gln Thr
Ser Gly Thr Gln
Ser Asn Ala Thr
Ser Asn Asp Gly
Ser Asn Gly Asp
Ser Asn Thr Ala
Ser Gln Ala Ser
Ser Gln Gly Thr
Ser Gln Ser Ala
Ser Gln Thr Gly
Ser Ser Ala Gln
Ser Ser Gln Ala
Ser Thr Ala Asn
Ser Thr Gly Gln
Ser Thr Asn Ala
Ser Thr Gln Gly
Thr Ala Asn Ser
Thr Ala Ser Asn
Thr Gly Asn Thr
Thr Gly Gln Ser
Thr Gly Ser Gln
Thr Gly Thr Asn
Thr Asn Ala Ser
Thr Asn Gly Thr
Thr Asn Ser Ala
Thr Asn Thr Gly
Thr Gln Gly Ser
Thr Gln Ser Gly
Thr Ser Ala Asn
Thr Ser Gly Gln
Thr Ser Asn Ala
Thr Ser Gln Gly
Thr Thr Gly Asn
Thr Thr Asn Gly
Val Cys Gly Asn
Val Cys Asn Gly
Val Gly Cys Asn
Val Gly Asn Cys
Val Asn Cys Gly
Val Asn Gly Cys
Lys-His-OH
C17H21N5O6 (391.14917660000003)
JWH 398 N-(5-hydroxypentyl) metabolite
C24H22ClNO2 (391.13389820000003)
icas#9
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from (4R)-4-hydroxypentanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
icos#9
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside derived from 5-hydroxypentanoic acid. It is a metabolite of the nematode Caenorhabditis elegans.
Tetrabutylammonium dichlorobromate
C16H36BrCl2N (391.14080160000003)
Fluoroclebopride
Fluoroclebopride binds reversibly to dopamine receptors. 18F labeled fluoroclebopride has been used as a probe for studying D2/D3 receptor availability via PET in various monkey models[1][2].
[2-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl]trimethylammonium chloride
Thiazolidine, 3-[(4-butoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
(9H-FLUOREN-9-YL)METHYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE
BI-D1870
C19H23F2N5O2 (391.18197219999996)
BI-D1870 is an ATP-competitive, cell permeable and brain penetrated inhibitor of RSK isoforms, with IC50s of 31 nM/24 nM/18 nM/15 nM for RSK1/RSK2/RSK3/RSK4, respectively[1][2][3][4][5].
1,3-di-boc-2-(trifluoromethylsulfonyl)guanidine
C12H20F3N3O6S (391.1024856000001)
ethyl 1-cyclopropyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylate
C20H23F2N3O3 (391.17073919999996)
5-Methyl-7-phenyl-N-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine
C21H21N5O3 (391.16443160000006)
2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-
C20H22ClNO5 (391.11864320000007)
Fmoc-(R)-3-Amino-4-(2-furyl)-butyric acid
C23H21NO5 (391.14196560000005)
3-((BENZYLOXY)METHYL)-4-ISOPROPYL-1-(4-(TRIFLUOROMETHYL)PHENYL)-1H-1,2,4-TRIAZOL-5(4H)-ONE
C20H20F3N3O2 (391.15075360000003)
(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE
Tonabersat
C20H19ClFNO4 (391.0986576000001)
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent
3-3-(Trifluoromethyl)benzoylaminobenzene-boronic acid pinacol ester
C20H21BF3NO3 (391.15665020000006)
Latrepirdine
C21H27Cl2N3 (391.15819220000003)
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Latrepirdine dihydrochloride is a neuroactive compound with antagonist activity at histaminergic, α-adrenergic, and serotonergic receptors. Latrepirdine stimulates amyloid precursor protein (APP) catabolism and amyloid-β (Aβ) secretion.
1H-Azepine, hexahydro-1-[[[2-(4-methylphenyl)-4-quinazolinyl]thio]acetyl]- (9CI)
N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE
C18H21N3O5S (391.12018560000007)
Fmoc-(S)-3-Amino-4-(2-furyl)-butyric acid
C23H21NO5 (391.14196560000005)
Zidebactam
C13H21N5O7S (391.11616360000005)
C254 - Anti-Infective Agent > C258 - Antibiotic
7-((2-amino-2-(1-formylcyclopropyl)ethyl)amino)-6-fluoro-1-(2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
C19H19F2N3O4 (391.13435580000004)
tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate
C18H21N3O5S (391.12018560000007)
(5-acetamido-3,4-diacetyloxy-6-ethylsulfanyloxan-2-yl)methyl acetate
Tavapadon
C19H16F3N3O3 (391.11437020000005)
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].
2-[5,6-Bis-(4-methoxy-phenyl)-furo[2,3-d]pyrimidin-4-ylamino]-ethanol
C22H21N3O4 (391.15319860000005)
n-Hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide
C19H21NO6S (391.10895260000007)
Chloroquine Hydrochloride
C18H28Cl3N3 (391.13486980000005)
C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent
Dutogliptin tartrate
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Diethyl 1-benzyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate
BML-278 is a SIRT1 activator (EC150: 1 μM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2].
Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate
(4R)-4-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}valeric acid
5-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]pentanoic acid
3-Cyclohexyl-10-methyl-2-thiophen-2-ylpyrimido[4,5-b]quinoline-4,5-dione
C22H21N3O2S (391.13544060000004)
N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine
C17H22FN7O3 (391.17680740000003)
5-tert-butyl-3-(4-chlorophenyl)-N-(2-pyridinylmethyl)-7-pyrazolo[1,5-a]pyrimidinamine
C22H22ClN5 (391.15636420000004)
Unii-gmy695BP6Q
C21H15F2N5O (391.12446040000003)
TPA-023B is a high-affinity and orally active GABAA receptor α2/α3 subtype (Kis of 0.73 nM/2 nM) partial agonist and a α1 subtype (Ki of 1.8 nM) antagonist. TPA-023B has non-sedating anxiolytic-like properties[1].
Dimetotiazine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
Icotinib
C22H21N3O4 (391.15319860000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
2-amino-1-[3-(1,3-benzodioxol-5-ylamino)-2-phenyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl]ethanone
C21H21N5O3 (391.16443160000006)
D-Glucitol, 2-(acetylmethylamino)-2-deoxy-3,6-di-O-methyl-, 1,4,5-triacetate
4,8-dimethoxyfuro[2,3-b]quinolin-7-yl 6-deoxy-beta-D-allopyranoside
2-(glutathion-S-yl)-2-carboxypropane
C14H21N3O8S-2 (391.10493060000005)
(1R,2S,3S,4S,5R,6S,8R,9R,12R)-5,6-dihydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylate
(1S,2S,3S,4S,5S,8R,9R,12S)-5,12-dihydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylate
[(3S)-3-acetamido-4-[[(2S)-1-[[(1S)-1-carboxy-3-methylbutyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutyl]-oxido-oxophosphanium
1-[2-[(4-Anilino-1-carboxy-4-oxobutyl)amino]propanoyl]pyrrolidine-2-carboxylic acid
Dithiazaninum
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D004396 - Coloring Agents > D005456 - Fluorescent Dyes
3,3-Diethylthiadicarbocyanine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D004396 - Coloring Agents > D005456 - Fluorescent Dyes
4-[3-(4-Methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
C22H21N3O2S (391.13544060000004)
4-[3-(3-Methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
C22H21N3O2S (391.13544060000004)
4-(3,4-dimethoxyphenyl)-1-(2-methoxyethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester
6,7-diethoxy-3-[3-(2-oxo-1-pyrrolidinyl)propyl]-2-sulfanylidene-1H-quinazolin-4-one
C19H25N3O4S (391.15656900000005)
2-Hydroxybenzoic acid [2-(2-ethoxyanilino)-2-oxo-1-phenylethyl] ester
C23H21NO5 (391.14196560000005)
N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide
C21H17N3O3S (391.09905720000006)
N-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide
C16H17N5O5S (391.09503520000004)
(4E)-4-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-2,3-dihydro-1H-acridine-9-carboxylic acid
C23H21NO5 (391.14196560000005)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide
C18H18FN3O4S (391.1002000000001)
N-[[(2S,3S,4R)-3-[4-(4-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-pyridinecarboxamide
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-2-(3-pyridinylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-3,3,3-trifluoro-1-propanone
C20H20F3N3O2 (391.15075360000003)
[(2S,3S)-3-phenyl-1-(3-pyridinylmethyl)-6-(3,3,3-trifluoropropyl)-1,6-diazaspiro[3.3]heptan-2-yl]methanol
methyl 3-[(E)-(8-oxo-1,5,6,8-tetrahydro-2H-1,5-methanopyrido[1,2-a][1,5]diazocin-3(4H)-yl)diazenyl]-1H-indole-2-carboxylate
C21H21N5O3 (391.16443160000006)
1-(4-Nitrophenyl)-3-[(Z)-(1,3,3-trimethylindol-2-ylidene)methyl]pyrrolidine-2,5-dione
C22H21N3O4 (391.15319860000005)
Benzyl 4-(furan-2-yl)-2,7,7-trimethyl-5-oxo-4,4a,6,8-tetrahydroquinoline-3-carboxylate
(2E,4E)-1-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-9-yl)-4-methyl-5-phenylpenta-2,4-dien-1-one
(2R,3S,4S,5S,6R)-2-(4,8-dimethoxyfuro[2,3-b]quinolin-7-yl)oxy-6-methyloxane-3,4,5-triol
[2-[Acetyl(methyl)amino]-4,5-diacetyloxy-1-deuterio-3,6-dimethoxyhexyl] acetate
flavoxate
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BD - Drugs for urinary frequency and incontinence C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D000089162 - Genitourinary Agents > D064804 - Urological Agents
8-Methylamino-riboflavin
C17H21N5O6 (391.14917660000003)
2-Amino-5-((1-((carboxymethyl)amino)-3-(hexylthio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid
C16H29N3O6S (391.17769740000006)
acetylerucifoline
A pyrrolizine alkaloid that is erucifoline in which the primary hydroxy hydrogen has been replaced by an acetyl group.
5,10-dihydroxy-2,11-dimethyl-2-(4-methylpent-3-en-1-yl)-1-oxa-11-azatetracen-6-one
2-hydroxy-2-[(1s,10r,11r,13s)-7-hydroxy-5-methoxy-2,9-dioxo-11-propyl-12,15-dioxatetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadeca-3,5,7-trien-13-yl]ethanimidic acid
2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol
5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-3-methyl-1,2-dihydroisoquinolin-6-ol
3-({1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid
n-(7-methyl-1,4-dioxo-6-{[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}naphthalen-2-yl)ethanimidic acid
n-(2-{[2-hydroxy-6-(methoxycarbonyl)phenyl]-c-hydroxycarbonimidoyl}phenyl)pyridine-3-carboximidic acid
ancistroheynine a
{"Ingredient_id": "HBIN015995","Ingredient_name": "ancistroheynine a","Alias": "NA","Ingredient_formula": "C24H25NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(=N1)C)OC)C3=C4C=C(C=C(C4=C(C=C3)OC)O)C)O","Ingredient_weight": "391.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1144","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135419358","DrugBank_id": "NA"}
ancistroheynine b
{"Ingredient_id": "HBIN015996","Ingredient_name": "ancistroheynine b","Alias": "NA","Ingredient_formula": "C24H25NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(=N1)C)OC)C3=C(C4=C(C=CC=C4OC)C=C3C)O)O","Ingredient_weight": "391.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1145","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "135508453","DrugBank_id": "NA"}
ancistrolikokine d
{"Ingredient_id": "HBIN015997","Ingredient_name": "ancistrolikokine d","Alias": "NA","Ingredient_formula": "C24H25NO4","Ingredient_Smile": "CC1CC2=C(C(=O)C=C(C2=C(N1)C)OC)C3=C4C=C(C=C(C4=C(C=C3)OC)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1146","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,9s,13r,14r,15s,16s)-13-(acetyloxy)-15-hydroxy-4,5,14-trimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,11-tetraen-9-ium-9-olate
(3s)-7-(1-hydroxy-8-methoxy-3-methylnaphthalen-2-yl)-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-6-ol
3-{4-[(2r,3r,6s)-5-hydroxy-3-(hydroxymethyl)-6-(1h-indol-3-yl)-3,6-dihydro-2h-1,4-oxazin-2-yl]phenoxy}propanenitrile
C22H21N3O4 (391.15319860000005)
(1s,13r,14r,15s,16s)-13-(acetyloxy)-15-hydroxy-4,5,14-trimethoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,11-tetraen-9-ium-9-olate
5,6,10,11-tetramethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11,19-octaene
2-[(20r)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]acetaldehyde
C23H21NO5 (391.14196560000005)
1-{17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-20-yl}propan-2-one
C23H21NO5 (391.14196560000005)
(3r)-5-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-6-ol
(3s)-7-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-6-ol
(1r,8s,10s,11r,12s,13s)-11,13-dihydroxy-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-16-one
3-{[(1s)-1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
3-(2,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl)-5-[(4-hydroxyphenyl)methylidene]pyrrole-2,4-diol
n-{7-methyl-1,4-dioxo-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]naphthalen-2-yl}ethanimidic acid
3-[(1r,2r,4as,8ar)-2,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-5-(4-hydroxyphenyl)pyridine-2,4-diol
(3r)-7-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-3,4-dihydro-2h-isoquinolin-6-one
1-[(20r)-17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-20-yl]propan-2-one
C23H21NO5 (391.14196560000005)
[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]acetic acid
[(5r,7r,9z,12r,18r)-9-ethylidene-5-methyl-4,10-dioxo-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-en-7-yl]methyl acetate
1-[(20s)-17-hydroxy-18-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaen-20-yl]propan-2-one
C23H21NO5 (391.14196560000005)
(3r)-7-(1-hydroxy-8-methoxy-3-methylnaphthalen-2-yl)-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-6-ol
3-{4-[(2s,3s,6r)-5-hydroxy-3-(hydroxymethyl)-6-(1h-indol-3-yl)-3,6-dihydro-2h-1,4-oxazin-2-yl]phenoxy}propanenitrile
C22H21N3O4 (391.15319860000005)
3-[(1r,2r,4as,8ar)-2,6-dimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-5-[(4-hydroxyphenyl)methylidene]pyrrole-2,4-diol
(3r)-7-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-3,4-dihydroisoquinolin-6-ol
11,13-dihydroxy-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-16-one
1,2-bis({4-[(1e,3e)-4-carboxybuta-1,3-dien-1-yl]phenyl})-1-hydroxydiazenium
[C22H19N2O5]+ (391.12939040000003)
[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]acetic acid
2-[(20s)-17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]acetaldehyde
C23H21NO5 (391.14196560000005)
methyl (3s,4s,4ar,13bs)-3-hydroxy-4,13b-dimethyl-6-oxo-1h,2h,3h,4ah,5h,8h-naphtho[2,1-b]carbazole-4-carboxylate
6,11-dihydroxy-2,2,5-trimethyl-12-(3-methylbut-2-en-1-yl)-1-oxa-5-azatetraphen-10-one
2-[5-hydroxy-1-(1-hydroxyethyl)-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl]benzoic acid
3-{4-[5-hydroxy-3-(hydroxymethyl)-6-(1h-indol-3-yl)-3,6-dihydro-2h-1,4-oxazin-2-yl]phenoxy}propanenitrile
C22H21N3O4 (391.15319860000005)
(2s)-5,10-dihydroxy-2,11-dimethyl-2-(4-methylpent-3-en-1-yl)-1-oxa-11-azatetracen-6-one
2-{17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}acetaldehyde
C23H21NO5 (391.14196560000005)
(2s)-2-hydroxy-n-[(1s)-1-[(3s)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-2-[(2s)-5-oxooxolan-2-yl]ethanimidic acid
5,10-dihydroxy-2,2,11-trimethyl-12-(3-methylbut-2-en-1-yl)-1-oxa-11-azatetracen-6-one
1-[(20s)-18-hydroxy-17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl]propan-2-one
C23H21NO5 (391.14196560000005)
4,5,10,11-tetramethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11,20-octaene
(2s,3s,4r,5r,6s)-2-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-6-methyloxane-3,4,5-triol
(8r,11r,12s,13s)-11,13-dihydroxy-3,4,12-trimethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.1⁸,¹¹.0¹,¹⁰.0²,⁷]octadeca-2,4,6-trien-16-one
2-hydroxy-n-[1-(8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)-3-methylbutyl]-2-(5-oxooxolan-2-yl)ethanimidic acid
(3s)-5-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-3,4-dihydro-2h-isoquinolin-6-one
{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}acetic acid
1-{18-hydroxy-17-methoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-yl}propan-2-one
C23H21NO5 (391.14196560000005)
7,17,18-trimethoxy-21-methyl-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1,3,5,7,9,15,17,19-octaen-14-one
C22H21N3O4 (391.15319860000005)